Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CD66c/CEACAM6 Antibody (78NCA-90), PE

Catalog #:   FHE25622 Specific References (100) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: FCM
Accession: P40199
Overview

Catalog No.

FHE25622

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Conjugation

PE

Target

Normal cross-reacting antigen, Carcinoembryonic antigen-related cell adhesion molecule 6, CEACAM6, CD66c, NCA, Non-specific crossreacting antigen

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

P40199

Applications

FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

78NCA-90

Data Image
References

A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with 89Zr/131I-Labeled Tinurilimab., PMID:40178153

A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with 89Zr/131I-Labeled Tinurilimab., PMID:40178153

Identification of CD66c as a potential target in gastroesophageal junction cancer for antibody-drug conjugate development., PMID:39918687

Identification of CD66c as a potential target in gastroesophageal junction cancer for antibody-drug conjugate development., PMID:39918687

Broad-Spectrum Efficacy of CEACAM6-Targeted Antibody-Drug Conjugate with BET Protein Degrader in Colorectal, Lung, and Breast Cancer Mouse Models., PMID:39812376

Broad-Spectrum Efficacy of CEACAM6-Targeted Antibody-Drug Conjugate with BET Protein Degrader in Colorectal, Lung, and Breast Cancer Mouse Models., PMID:39812376

Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models., PMID:38467634

Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models., PMID:38467634

Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up., PMID:38432068

Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up., PMID:38432068

The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia., PMID:38378030

The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia., PMID:38378030

CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells., PMID:38178674

CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells., PMID:38178674

Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells., PMID:36614128

Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells., PMID:36614128

A new strategy to count and sort neutrophil-derived extracellular vesicles: Validation in infectious disorders., PMID:35362257

A new strategy to count and sort neutrophil-derived extracellular vesicles: Validation in infectious disorders., PMID:35362257

T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction., PMID:35141051

T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction., PMID:35141051

Antibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans., PMID:34847408

Antibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans., PMID:34847408

The Immunomodulatory CEA Cell Adhesion Molecule 6 (CEACAM6/CD66c) Is a Protein Receptor for the Influenza a Virus., PMID:33919410

The Immunomodulatory CEA Cell Adhesion Molecule 6 (CEACAM6/CD66c) Is a Protein Receptor for the Influenza a Virus., PMID:33919410

Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer., PMID:33838601

Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer., PMID:33838601

CEACAM3 decreases asthma exacerbations and modulates respiratory syncytial virus latent infection in children., PMID:32606071

CEACAM3 decreases asthma exacerbations and modulates respiratory syncytial virus latent infection in children., PMID:32606071

Neisseria gonorrhoeae Blocks Epithelial Exfoliation by Nitric-Oxide-Mediated Metabolic Cross Talk to Promote Colonization in Mice., PMID:32289262

Neisseria gonorrhoeae Blocks Epithelial Exfoliation by Nitric-Oxide-Mediated Metabolic Cross Talk to Promote Colonization in Mice., PMID:32289262

Enhanced E. coli LF82 Translocation through the Follicle-associated Epithelium in Crohn's Disease is Dependent on Long Polar Fimbriae and CEACAM6 expression, and Increases Paracellular Permeability., PMID:31393983

Enhanced E. coli LF82 Translocation through the Follicle-associated Epithelium in Crohn's Disease is Dependent on Long Polar Fimbriae and CEACAM6 expression, and Increases Paracellular Permeability., PMID:31393983

Stromal fibroblasts induce metastatic tumor cell clusters via epithelial-mesenchymal plasticity., PMID:31331982

Stromal fibroblasts induce metastatic tumor cell clusters via epithelial-mesenchymal plasticity., PMID:31331982

Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia., PMID:30730614

Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia., PMID:30730614

The interaction between carcinoembryonic antigen-related cell adhesion molecule 6 and human epidermal growth factor receptor 2 is associated with therapeutic efficacy of trastuzumab in breast cancer., PMID:30058236

The interaction between carcinoembryonic antigen-related cell adhesion molecule 6 and human epidermal growth factor receptor 2 is associated with therapeutic efficacy of trastuzumab in breast cancer., PMID:30058236

Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation., PMID:28892050

Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation., PMID:28892050

A CEACAM6-High Airway Neutrophil Phenotype and CEACAM6-High Epithelial Cells Are Features of Severe Asthma., PMID:28275137

A CEACAM6-High Airway Neutrophil Phenotype and CEACAM6-High Epithelial Cells Are Features of Severe Asthma., PMID:28275137

Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display., PMID:28062646

Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display., PMID:28062646

Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia., PMID:27438018

Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia., PMID:27438018

CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer., PMID:27421133

CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer., PMID:27421133

Monoclonal Antibody 1B5A5 Against CEACAM6., PMID:27328063

Monoclonal Antibody 1B5A5 Against CEACAM6., PMID:27328063

Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells., PMID:27172290

Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells., PMID:27172290

Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity., PMID:26204223

Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity., PMID:26204223

Influenza A virus infection of intestinal epithelial cells enhances the adhesion ability of Crohn's disease associated Escherichia coli strains., PMID:25706391

Influenza A virus infection of intestinal epithelial cells enhances the adhesion ability of Crohn's disease associated Escherichia coli strains., PMID:25706391

Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies., PMID:27595061

Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies., PMID:27595061

CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas., PMID:25427744

CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas., PMID:25427744

CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway., PMID:25398131

CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway., PMID:25398131

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6., PMID:23603913

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6., PMID:23603913

Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells., PMID:22918079

Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells., PMID:22918079

Molecular targeting of CEACAM6 using antibody probes of different sizes., PMID:22568933

Molecular targeting of CEACAM6 using antibody probes of different sizes., PMID:22568933

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease., PMID:21994005

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease., PMID:21994005

Use of Cre/loxP recombination to swap cell binding motifs on the adenoviral capsid protein IX., PMID:21968200

Use of Cre/loxP recombination to swap cell binding motifs on the adenoviral capsid protein IX., PMID:21968200

Single-domain antibody bioconjugated near-IR quantum dots for targeted cellular imaging of pancreatic cancer., PMID:21780366

Single-domain antibody bioconjugated near-IR quantum dots for targeted cellular imaging of pancreatic cancer., PMID:21780366

Isolation of functional single domain antibody by whole cell immunization: implications for cancer treatment., PMID:21741385

Isolation of functional single domain antibody by whole cell immunization: implications for cancer treatment., PMID:21741385

[Cells antigens' expression modulation during induction treatment of childhood acute lymphoblastic leukemia]., PMID:21344762

[Cells antigens' expression modulation during induction treatment of childhood acute lymphoblastic leukemia]., PMID:21344762

New targets of pemphigus vulgaris antibodies identified by protein array technology., PMID:21255096

New targets of pemphigus vulgaris antibodies identified by protein array technology., PMID:21255096

Development of a high-resolution purification method for precise functional characterization of primitive human cord blood-derived CD34-negative SCID-repopulating cells., PMID:21112372

Development of a high-resolution purification method for precise functional characterization of primitive human cord blood-derived CD34-negative SCID-repopulating cells., PMID:21112372

Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells., PMID:20380867

Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells., PMID:20380867

[Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia]., PMID:19573409

[Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia]., PMID:19573409

Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma., PMID:19334050

Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma., PMID:19334050

Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer., PMID:19244123

Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer., PMID:19244123

Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells., PMID:19077207

Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells., PMID:19077207

Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells., PMID:18552205

Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells., PMID:18552205

Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemias., PMID:18299959

Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemias., PMID:18299959

High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias., PMID:17909799

High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias., PMID:17909799

All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias., PMID:17561254

All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias., PMID:17561254

Datasheet
$ 258
Product specifications
50 T 258 100 T 426

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CD66c/CEACAM6 Antibody (78NCA-90), PE [FHE25622]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only